Johnson & Johnson

mClinica develops mobile platforms that strengthen the pharmaceutical supply chain, generate data, improve patient adherence to medication, and build the capacity of the pharmacy workforce. Since 2017, mClinica has connected 150,000 pharmacy professionals and 40,000 pharmacies through a single digital channel. Their users reach approximately 150 million patients each month. mClinica currently operates across Indonesia, Philippines, Vietnam, Cambodia, Thailand, Malaysia, and Singapore with capacity for expansion. Their team is composed of over 120 team members including experts in public health, data science, and pharmacy. mClinica is supported by impact investors like the Global Innovation Fund (backed by USAID, UKAID, DFAT, Swedish Government, and the Omidyar Network) and Patamar Capital (formerly Unitus Impact) as well as other investors from the US, Europe, and Asia. mClinica implements projects both digitally and on the ground to connect the world’s pharmacies and transform global health. mClinica follows a social enterprise business model in which they seek double-bottom line returns – maximizing both financial returns and social impact. mClinica’s rapid growth and success is increasingly recognized. mClinica was the recipient of the Data Driven Apps Award of the World Government Summit in 2019, USAID-FHI360 Data for Resilience Award, Pierre Fabre Foundation Prize for eHealth Innovation, and Hack Osaka. The company has consistently been recognized as one of the most innovative startups in healthcare in Asia Pacific.

Developer of a clinical decision support tool designed to leverage machine learning and the power of cloud computing to help maintain clinical guidelines at the point of care. The company's platform focuses on ensuring proper diagnosis and treatment of Atrial Fibrillation (AFib) in the Emergency Department provides clinicians tools to confidently identify AFib and initiate guideline-recommended treatment in order to prevent strokes, enabling clinicians to save lives, improve outcomes, and low overall healthcare costs by adhering to guidelines.

Developer of a mobile application designed to facilitate fluid conversations between people hailing from marginalized groups and healthcare providers. The company's application uses storytelling to improve patient experience and population health by offering users a safe digital space, where they can talk about their health concerns and social needs without the fear of judgment or biased treatment from healthcare providers, enabling underserved people from marginalized communities to have greater access to basic health care resources.

Ayana Therapy is a telehealth platform dedicated to providing mental health services to marginalized communities, including people of color and LGBTQ+ individuals. It utilizes a smart matchmaking algorithm to connect users with licensed therapists who are compatible based on cultural experiences and identity traits such as race, gender identity, class, sexuality, and ethnicity. By offering virtual communication options, Ayana Therapy aims to address significant barriers to mental health care, including high costs, stigma, and a lack of cultural competency within the healthcare system. The platform seeks to create a safe space for those whose voices have been historically dismissed or neglected, facilitating access to essential mental health support.

TQIntelligence, Inc. owns and operates a platform which measures the severity of the emotional distress. The platform integrates multiple data sources and offers cognitive insights into risk stratification, treatment outcomes tracking, and personalized behavioral health interventions. The company products include TQ-Intelligence, including insights from voice/speech analytics and other psychometrically sound instruments and TQ Analytics which offers solutions using existing EMR data with actionable insights. The company features include machine learning analytics, knowledge graph, and real time prediction. TQIntelligence, Inc. was founded in 2016 and is headquartered in Atlanta, Georgia.

Radical Health hosts conversations with AI-enabled tech that helps people understand what's going on with their health. Radical Health works at the intersection of community health and tech. The company combines meaningful conversations with AI-enabled tech that helps people understand what's going on during a visit, build trust, and develop self-advocacy. Radical Health hosts in-person workshops and training designed to elicit deeper conversations around the Social Determinants of Health (SDoH) within communities and for providers. It combines those programs with Radical Relay, an AI-based chat app that empowers individuals to "Know Their Rights" throughout pregnancy, COVID19, and beyond. We help you ask the right questions during a visit to ensure equity for all. Founded in the Bronx, Radical Health is an Afro-Latina led social enterprise.

Biotechnology company specializing in the characterization and process engineering of complex molecules

TARIS BioMedical, Inc., a therapeutically urology company, develops treatments for patients suffering from difficult-to-treat bladder diseases. It develops therapies for debilitating conditions, including bladder cancer and overactive bladder. The company was founded in 2008 and is based in Lexington, Massachusetts. As of December 20, 2019, TARIS BioMedical, Inc. operates as a subsidiary of Janssen Research & Development, LLC.

Verb Surgical Inc., established in 2015 and based in Santa Clara, California, is a company focused on developing a digital surgery platform aimed at enhancing surgical procedures. This platform integrates robotics, advanced visualization, innovative instrumentation, data analytics, and connectivity to support operating room professionals. By leveraging these technologies, Verb Surgical seeks to improve patient outcomes and reduce the overall cost of care, ultimately striving to democratize access to surgical solutions. As a subsidiary of Johnson & Johnson Innovation - JJDC, Inc., Verb Surgical is positioned to make significant advancements in the field of surgery.

Developer of ultrasonic devices intended to provide safety to pregnant mothers. The company's platform uses smart device technology to reduce maternal mortality rates by ensuring early detection and management of risk factors of maternal and neonatal mortality, enabling caregivers to treat pregnant mothers in resource-scarce environments.

DayTwo Ltd. is a precision medicine company based in Tel Aviv-Yafo, Israel, that focuses on using gut microbiome analysis to provide personalized health solutions for metabolic diseases such as diabetes, prediabetes, and obesity. Founded in 2015, the company utilizes gut microbiome sequencing to create tailored Food Prescriptions™ that help individuals manage their blood sugar levels, improve energy, and achieve weight loss. Their digital platform offers actionable dietary recommendations based on individual biometrics and lifestyle factors, ensuring that patients receive insights that are practical and easy to follow. DayTwo also employs a telehealth service, where Certified Diabetes Care and Education Specialists and Registered Dietitians support patients through a smartphone application, allowing for progress tracking and communication. The effectiveness of DayTwo's approach is measured using clinical outcomes such as A1C levels and Time In Range, with the potential for full fee reimbursement for those who adhere to the protocol.

Oncochain is developing a real-world data platform in oncology to standardize, collect and aggregate anonymized data from patients who suffer from cancer. This creates the possibility to generate useful analytics that can orientate research for pharma companies and help healthcare providers deliver value-based care. Our proprietary method of collection is a web-based Oncology specific EHR that acts as a software platform creating operational data repositories for RWD studies. We greatly aid the informational flow between providers and upskill oncology professionals. We support research by reducing recruitment times in clinical trials and by creating the necessary framework for multi-centric studies design and implementation. Oncochain SaaS Analytics Tool offers much-needed RWD insights for clients like pharma companies and CROs.

Auris Health, Inc. is a company based in Redwood City, California, focused on developing advanced robotics technology for medical applications. Founded in 2007, it specializes in creating innovative solutions for diagnostic and therapeutic bronchoscopic procedures. The company's flagship product, the Monarch Platform, utilizes small cameras and instruments to facilitate endoscopic procedures through natural body openings. This platform incorporates cutting-edge advancements in imaging technology, robotics, endoscope design, sensing, and data science, aiming to enhance patient outcomes and reduce medical costs. Additionally, Auris Health is developing a dual-arm microsurgical system designed for ophthalmic surgery, further expanding its capabilities in the medical robotics field. As a subsidiary of Johnson & Johnson, Auris Health continues to transform medical intervention through its integration of various technological innovations.

Ci:z Holdings Co., Ltd. is a Japanese company engaged in the development, manufacture, and sale of cosmetics, health foods, beauty care products, and related items. Established in 1999 and headquartered in Tokyo, the company offers a range of skin care cosmetics, including functional products designed for various skin concerns, and health supplements aimed at enhancing beauty and wellness. Its products are marketed under the Dr.Ci:Labo and Genomer brand names, and are distributed through multiple channels, including mail order, wholesale to drug stores and cosmetics shops, and directly operated retail stores in department stores and shopping centers. Ci:z Holdings operates both domestically and internationally, with a presence in markets such as Taiwan, Hong Kong, and the United States.

Zarbee's, Inc. is a company that manufactures and sells a variety of health products, including cough and throat relief items, immune support solutions, and vitamins and supplements for both children and adults. Established in 2008 and headquartered in Draper, Utah, Zarbee's also has a presence in Greenwich, Connecticut. The company provides its products through both physical and online retail channels. In addition to its product offerings, Zarbee's emphasizes the importance of natural health by providing clinically proven health tips and advice for families. As of September 2018, Zarbee's operates as a subsidiary of Johnson & Johnson Consumer Inc.

Cue Health Inc. is a healthcare technology company based in San Diego, California, specializing in the development and manufacturing of diagnostic screening devices for home use. Founded in 2010, the company offers a connected diagnostic platform known as the Cue Health Monitoring System, which allows users to conduct self-serve tests that provide lab-quality results. This platform enables individuals to track key health indicators, including inflammation, vitamin D, fertility, influenza, and testosterone, through a user-friendly device that connects to a smartphone app. The Cue app not only displays test results but also integrates data on lifestyle factors such as activity and sleep, facilitating a comprehensive view of health at a molecular level. Additionally, Cue Health provides various services for healthcare professionals, including tools for managing patient test histories and telemedicine consultations. The company's innovative approach empowers consumers and healthcare providers alike to access critical health information easily and effectively.

Dreem is a neurotechnology company focused on enhancing human potential through innovative consumer technology. Its primary product is a wearable device that improves the quality of deep sleep by monitoring brainwaves and analyzing sleep patterns. The device employs sound stimulation to extend deep sleep duration, which can lead to improved daily performance. By utilizing machine learning algorithms, Dreem's headband provides real-time analysis of sleep stages and delivers personalized insights and tips that adapt based on individual sleeping habits. This approach aims to help users achieve faster sleep onset, longer deep sleep, and a refreshed awakening.

Orthotaxy SAS, founded in 2009 and based in La Tronche, France, specializes in the development and manufacturing of robotic systems designed for orthopedic surgery. The company focuses on creating software-enabled surgical technologies aimed at enhancing patient outcomes. As of February 2018, Orthotaxy SAS operates as a subsidiary of Apsis S.A.S.

Bloomlife is a women's health company focused on improving maternal health by addressing significant global challenges. It offers a comprehensive remote maternal care platform that combines connected devices with data analytics to enhance access to care and provide personalized feedback to expectant mothers. Central to Bloomlife's solution is a prenatal wearable device that monitors critical health parameters for both maternal and fetal well-being. This technology helps identify modifiable risk factors, detect abnormalities, and predict potential complications, enabling healthcare providers to manage pregnancies more effectively. By promoting early detection and intervention, Bloomlife aims to support families in achieving a healthy start.

Prapela is a health and wellness company.SVS than any other infant health and wellness company in the world. It's the result of ten years of effort in the science, product development and clinical evaluation of SVS at Harvard’s Wyss Institute for Biologically Inspired Engineering, the University of Massachusetts Memorial Medical Center and Massachusetts General Hospital.

DayTwo Ltd. is a precision medicine company based in Tel Aviv-Yafo, Israel, that focuses on using gut microbiome analysis to provide personalized health solutions for metabolic diseases such as diabetes, prediabetes, and obesity. Founded in 2015, the company utilizes gut microbiome sequencing to create tailored Food Prescriptions™ that help individuals manage their blood sugar levels, improve energy, and achieve weight loss. Their digital platform offers actionable dietary recommendations based on individual biometrics and lifestyle factors, ensuring that patients receive insights that are practical and easy to follow. DayTwo also employs a telehealth service, where Certified Diabetes Care and Education Specialists and Registered Dietitians support patients through a smartphone application, allowing for progress tracking and communication. The effectiveness of DayTwo's approach is measured using clinical outcomes such as A1C levels and Time In Range, with the potential for full fee reimbursement for those who adhere to the protocol.

Pulmocide Ltd is a London-based company established in 2007 that specializes in developing inhaled medicines aimed at treating serious viral and fungal infections of the respiratory tract. The company focuses on creating a new generation of antifungal drugs tailored for inhalation, which enhances the delivery of medication directly to the lungs while reducing systemic exposure. This targeted approach is designed to improve efficacy against respiratory aspergillosis and minimize systemic toxicities, thereby offering safe and effective treatment options for patients with acute and chronic respiratory diseases.

Actelion Ltd is a biopharmaceutical company based in Allschwil, Switzerland, founded in 1997. The company specializes in the discovery, development, and commercialization of low molecular weight drugs aimed at addressing unmet medical needs. Its primary focus is on pulmonary arterial hypertension (PAH), offering several treatments including Tracleer, Opsumit, Uptravi, Ventavis, and Veletri, which utilize various methods of administration to manage the disease. Additionally, Actelion provides Zavesca, an oral medication for mild to moderate type 1 Gaucher disease, and Valchlor, a topical treatment for a rare form of cutaneous T-cell lymphoma. The company has established a global commercial presence for its orphan drugs and continues to enhance its product pipeline through in-licensing and acquisitions. Actelion markets its products in multiple regions, including the United States, Europe, Japan, and Switzerland, and operates as a subsidiary of Johnson & Johnson.

Raybaby is a baby monitor that tracks respiration and sleep pattern. It alerts when the baby has a higher respiratory rate which is associated with fever and other conditions. Raybaby also comes equipped with integrated infrared video camera which enables live video streaming even in pitch darkness, built in speakers, and audio monitoring that uses a highly sensitive microphone.

Neurotrack Technologies, Inc., founded in 2012 by Elli Kaplan and neuroscientist Dr. Stuart Zola, is based in Redwood City, California. The company focuses on transforming the diagnosis and prevention of Alzheimer’s and related dementias through its innovative app-based Cognitive Health Program. Neurotrack offers a computer-based cognitive test that detects impairment in the hippocampus, a key area affected by Alzheimer’s. Utilizing advanced eye-tracking technology, the company provides digital cognitive assessments alongside a personalized intervention program. This approach empowers individuals of all ages to enhance their cognitive health through regular “brain checkups” and targeted lifestyle changes, aiming to improve overall cognitive function and prevent dementia-related conditions.

Abbott Laboratories is a global healthcare company that specializes in the discovery, development, manufacturing, and sale of a wide range of health care products. Established in 1888 and headquartered in North Chicago, Illinois, Abbott operates across various segments, including Established Pharmaceuticals, Diagnostics, Nutritional Products, and Medical Devices. The Established Pharmaceuticals segment offers generic drugs and treatments for multiple conditions, including diabetes and hypertension. The Diagnostics segment provides advanced laboratory systems for detecting infectious diseases and metabolic disorders. Abbott's Nutritional Products division focuses on pediatric and adult nutrition, while the Medical Devices segment supplies devices for cardiovascular treatment and glucose monitoring. Abbott is also recognized for its innovative contributions, such as the first HIV blood-screening test, and maintains a commitment to developing integrated diabetes solutions. With a workforce of approximately 90,000 employees, the company operates in over 130 countries, continuously striving to enhance health outcomes through its diverse product offerings.

Ci:z Holdings Co., Ltd. is a Japanese company engaged in the development, manufacture, and sale of cosmetics, health foods, beauty care products, and related items. Established in 1999 and headquartered in Tokyo, the company offers a range of skin care cosmetics, including functional products designed for various skin concerns, and health supplements aimed at enhancing beauty and wellness. Its products are marketed under the Dr.Ci:Labo and Genomer brand names, and are distributed through multiple channels, including mail order, wholesale to drug stores and cosmetics shops, and directly operated retail stores in department stores and shopping centers. Ci:z Holdings operates both domestically and internationally, with a presence in markets such as Taiwan, Hong Kong, and the United States.

Vogue International LLC, headquartered in Clearwater, Florida, is a manufacturer and distributor of hair care and personal care products. Founded in 1987, the company offers a diverse range of products, including the FX™ line of hair styling items and the award-winning OGX® collection, which features shampoos, conditioners, and styling/treatment products. Vogue's products are designed with exotic ingredients and are free from harmful sulfates, appealing to a health-conscious consumer base. The company distributes its offerings through major retail channels, both in the United States and across 42 international markets. Vogue International is recognized for its commitment to innovation, sustainability, and delivering salon-quality products, maintaining a strong presence in the competitive beauty industry. As of 2016, Vogue operates as a subsidiary of Johnson & Johnson Consumer Inc.

Suncayr Inc., located in Mississauga, Canada, has developed an innovative colour-changing sticker called "SPOT" designed to enhance sun safety. This sticker is applied directly to the skin before sunscreen is used. While the sunscreen effectively blocks ultraviolet (UV) rays, the sticker remains clear; however, once the sunscreen's protective qualities diminish and UV exposure occurs, the sticker changes to purple. This simple yet effective tool provides users with clear visual feedback on their sunscreen's effectiveness, allowing families to enjoy outdoor activities with greater confidence in their sun protection.

TESARO, Inc. is an oncology-focused biopharmaceutical company established in 2010 and based in Waltham, Massachusetts. The company specializes in the identification, acquisition, development, and commercialization of cancer therapeutics and supportive care products. Its notable offerings include ZEJULA, an oral poly polymerase inhibitor used for the maintenance treatment of recurrent ovarian cancer, and VARUBI, a neurokinin-1 receptor antagonist designed to prevent chemotherapy-induced nausea and vomiting. TESARO is also advancing a range of immunotherapy candidates, such as TSR-042, TSR-022, and TSR-033, all currently in phase I clinical trials. The company has formed various collaboration and licensing agreements with industry partners, including AnaptysBio, Janssen Biotech, and Genentech. In January 2019, TESARO became a subsidiary of GlaxoSmithKline plc, further enhancing its capabilities in cancer treatment innovation.

Novira Therapeutics, Inc., a clinical-stage biopharmaceutical company, discovers and develops antiviral drugs for the treatment of chronic hepatitis B infection. It develops core and cccDNA inhibitor anti-HBV drugs. Novira Therapeutics, Inc. was formerly known as Molecmo Nanobiotechnologies, Inc. The company was incorporated in 2006 and is based in Doylestown, Pennsylvania. As of December 4, 2015, Novira Therapeutics, Inc. operates as a subsidiary of Johnson & Johnson.

NeoStrata Company, Inc., based in Princeton, New Jersey, specializes in the development and marketing of a wide array of therapeutic and cosmetic dermatological products. The company offers clinically-proven brands, including NeoStrata, Exuviance, CoverBlend, NeoCeuticals, and NeoStrata Therapeutics, featuring advanced Polyhydroxy Acid technology. Its product lineup addresses various skin concerns such as aging signs, acne, hyperpigmentation, and conditions like psoriasis and seborrheic dermatitis. Offerings include cleansers, moisturizers, serums, and specialized treatments designed to conceal imperfections and rejuvenate the skin. NeoStrata products are available globally through consumer outlets, dermatologists, plastic surgeons, pharmacies, and beauty retailers. Founded in 1988 by Drs. Van Scott and Yu, the company is recognized for its pioneering research on Alpha Hydroxy Acids and their effects on skin health. As of 2016, NeoStrata operates as a subsidiary of Johnson & Johnson Consumer Inc.

Inter-Grosshandel offers wide range of wholesale brand clothing

U.K.-based cardiovascular drug startup

Jagdale Industries Pvt Ltd(JIPL) is a part of the well-established and one-of-the-oldest industrial family group of Bengaluru: ‘The Jagdale family’. The roots of Jagdale go back to 1939 when Associated Drugs Company Ltd., was set up and to the contributions of Late Shri. Radhakrishna Jagdale, founder Jagdale group. JIPL has pioneered several products including unique food, beverage, nutraceutical and pharmaceutical formulations, in line with the nation’s needs and market requirements.

Alios is discovering and developing novel therapeutic agents based on three platform technologies including: small molecule activators of innate immunity antiviral pathways (RNase L activation), phosphate protected nucleotide prodrug chemistry, and glycoprotein-engineering of interferons (Glycoferonâ). This complementary group of platform technologies has the potential to generate a number of distinct therapeutic products to treat a variety of serious viral infections such as chronic hepatitis B and C, HIV infection, and respiratory viruses (e.g. pandemic influenza) and emerging viral diseases (e.g. SARS).

DePuy Synthes is a multinational medical device manufacturer specializing in the production of implants and biomaterials for surgical fixation, joint reconstruction, trauma, and spinal surgery. With operations based in Solothurn, Switzerland, and West Chester, Pennsylvania, the company offers a diverse range of products, including clavicle plate systems, olecranon plates, anterior cervical interbody systems, and various orthopedic solutions. Its portfolio also features high-speed pneumatic systems and materials such as antioxidant polyethylene, catering to the needs of healthcare professionals in the orthopedic field. DePuy Synthes is recognized for its commitment to advancing surgical techniques and improving patient outcomes through innovative medical technologies.

Aragon Pharmaceuticals is a discovery-stage small molecule company dedicated to developing therapeutics for hormone-resistant cancers, particularly focusing on prostate and breast cancer. The company specializes in anti-endocrine therapies that target the biology of these cancers. Its research emphasizes nuclear receptor biology, medicinal chemistry, and drug discovery, with the goal of identifying and developing selective androgen receptor degraders for prostate cancer and selective estrogen receptor degraders for estrogen-sensitive breast cancer.

Manufacturer of baby skin care products. The company offers body wash, shampoo and talcum powder for babies. It also provides products for pregnant mothers.

Calibra Medical, Inc. develops medical devices and technologies in the diabetes sector. It offers insulin delivery devices. The company was formerly known as Seattle Medical Technologies, Inc. Calibra Medical, Inc. was founded in 2004 and is based in Redwood City, California.

SterilMed is a contracting manufacturer that specializes in the refurbishing and reprocessing of medical devices and equipment. The company offers services that include the repair and remanufacturing of a variety of medical instruments, such as flexible endoscope systems, power equipment, and surgical instrumentation. SterilMed caters to over 1,700 healthcare facilities across North America, providing essential support for the maintenance and sustainability of medical technologies.

Crucell is a global biopharmaceutical company that specializes in the research, development, production, and marketing of vaccines, proteins, and antibodies aimed at preventing and treating infectious diseases. The company offers a diverse portfolio of vaccines, including those for hepatitis B, a fully-liquid vaccine that addresses five significant childhood diseases, and a virosome-adjuvanted vaccine for influenza. Additionally, Crucell provides travel vaccines, notably the only oral anti-typhoid vaccine, an oral cholera vaccine, and the sole aluminum-free hepatitis A vaccine available. Its products are distributed in both public and private markets around the world.

Micrus Endovascular Corporation develops and manufactures both implantable and disposable medical devices used in the treatment of cerebral vascular diseases. Micrus Endovascular develops products that can be used by interventional neuroradiologists, interventional neurologists, and endovascularly trained neurosurgeons to treat both cerebral aneurysms responsible for hemorrhagic stroke and intracranial atherosclerosis, which may lead to ischemic stroke. The Micrus Endovascular product lines enable physicians to gain access to the brain in a minimally invasive manner through the vessels of the arterial system. It also sells stents, balloon catheters, access devices such as guide catheters, microcatheters, guidewires, and accessory products used in conjunction with its microcoils. Micrus Endovascular Corporation wasfounded in 1996 and is based in San Jose, California. As of September 27, 2010, Micrus Endovascular LLC operates as a subsidiary of Codman & Shurtleff, Inc.

Acclarent, Inc., founded in June 2004 and located in Menlo Park, California, is a medical device company focused on developing innovative technologies for ear, nose, and throat (ENT) patients. The company specializes in balloon sinuplasty devices, which are minimally invasive tools designed to assist physicians in treating chronic sinusitis. These devices enable doctors to navigate sinus anatomy, effectively opening blocked sinus ostia and passageways to facilitate drainage. Acclarent's commitment to advancing ENT solutions is reflected in their product portfolio, which offers alternatives to traditional endoscopic surgical methods. The company's devices received FDA clearance and were commercially launched in the United States in 2005, marking a significant step in enhancing patient care in sinus surgery. Through ongoing innovation, Acclarent aims to expand its offerings across various areas of ENT.

Crucell is a global biopharmaceutical company that specializes in the research, development, production, and marketing of vaccines, proteins, and antibodies aimed at preventing and treating infectious diseases. The company offers a diverse portfolio of vaccines, including those for hepatitis B, a fully-liquid vaccine that addresses five significant childhood diseases, and a virosome-adjuvanted vaccine for influenza. Additionally, Crucell provides travel vaccines, notably the only oral anti-typhoid vaccine, an oral cholera vaccine, and the sole aluminum-free hepatitis A vaccine available. Its products are distributed in both public and private markets around the world.

Omrix Biopharmaceuticals, Inc., a biopharmaceutical company, develops, manufactures, and markets biological products for the biosurgical and immunotherapy markets.

HealthMedia, founded in 1998 by Dr. Victor Strecher, specializes in scalable behavior change interventions aimed at health and wellness, disease management, and medication compliance. The company has developed innovative programs that replicate the benefits of health coaching sessions without the need for an actual coach. Its unique methodology and technology deliver effective outcomes similar to traditional health coaching while leveraging the scalability of web content. HealthMedia also creates specialized programs for pharmaceutical companies and medical device manufacturers, addressing a range of health issues, including drug and alcohol addiction, mental illness, and chronic conditions such as hypertension and heart disease.

Beijing Dabao Cosmetics Co., Ltd. is a manufacturer based in Beijing, China, specializing in herbal cosmetic products. The company develops, produces, and sells a wide range of items, including face wash, moisturizer, sunscreen, shampoo, and various other skincare products. In addition to its domestic market, Beijing Dabao also exports its products internationally, catering to a growing demand for herbal and natural cosmetics.

Conor MedSystems specializes in the development of controlled drug delivery technologies for vascular applications, primarily focusing on drug-eluting stents designed to treat coronary artery disease and restenosis. The company aims to enhance the effectiveness of vascular stents by incorporating mechanisms that allow for localized drug delivery to both coronary and peripheral vessels. Through its innovative approach, Conor MedSystems seeks to improve patient outcomes in the management of vascular conditions.

InnerPulse, Inc. develops technology, devices, software protocols, and procedures to transform the treatment of cardiac arrhythmias. It offers invasive treatment that enables physicians to implant the life-saving Percutaneous Implantable Cardioverter Defibrillator within the patient's vascular system. InnerPulse, Inc. was formerly known as Interventional Rhythm Management, Inc.

CardioMEMS is a medical device company that has developed and is commercializing a proprietary wireless sensing and communication technology for the human body. Their technology platform is designed to improve the management of severe chronic cardiovascular diseases such as heart failure and aneurysms. Their miniature wireless sensors can be implanted using minimally invasive techniques and transmit cardiac output, blood pressure and heart rate data that are critical to the management of patients.

Groupe Vendome SA manufactures adult and baby skin care products.

Peninsula Pharmaceuticals, Inc. is a specialty pharmaceutical company dedicated to the licensing, development, and commercialization of anti-infective therapies aimed at treating life-threatening infections in North America and Europe. The company's primary focus is on its lead product candidate, doripenem, a broad-spectrum antibiotic classified as a carbapenem. Currently, Peninsula is conducting six Phase III clinical trials for doripenem, which has also received Fast Track designation from the U.S. Food and Drug Administration for the treatment of nosocomial pneumonia, including ventilator-associated pneumonia. The company was acquired by Johnson & Johnson, a global leader in healthcare products and services. As a privately held biopharmaceutical entity, Peninsula Pharmaceuticals concentrates on advancing antibiotics to address critical infection-related health challenges.

Transform Pharmaceuticals was a pharmaceuticals company specializing in the discovery of improved formulations and novel crystalline forms of drug molecules. Transform’s product portfolio included Topiramate, an anti-epileptic drug. The company was acquired by Johnson & Johnson in 2005. The company was founded in 1998.

TopSpin Medical developed an innovative and unique technology for high-resolution MRI using an IntraVascular MRI (IVMRI) catheter for the coronary arteries, without the need for an expensive and bulky external MRI setup. The catheter contains those components, which are usually found in a conventional MRI scanner, only that they are miniaturized to less than 2 millimeters in size.

Tibotec is a biopharmaceutical company focused on developing anti-viral treatments, with several promising compounds in development for the treatment of infectious diseases including HIV.

LXN Corporation is a medical technology company that develops, manufactures, and markets products to help people with diabetes better manage their disease. The company offers GlucoProtein, a home-based test that measures overall glucose control. It allows patients and healthcare professionals to better monitor the overall effectiveness of diabetes treatments and make timely and effective therapy changes. LXN Corporation was founded in 1994 and is based in San Diego, California.

BabyCenter, L.L.C. is a prominent digital resource for pregnancy and parenting information, catering to new and expectant parents in the United States and internationally. Founded in 1997 and headquartered in San Francisco, California, the company provides guidance on various topics, including pregnancy, baby care, and early childhood development. BabyCenter offers a wide range of services, including product reviews, buying guides, and a storefront for purchasing baby-related merchandise. The platform also fosters a sense of community through bulletin boards, online chat sessions, and question-and-answer forums, allowing parents to connect with each other and with medical professionals. As a subsidiary of Everyday Health Media LLC, BabyCenter continues to be a leading source of support and information for families navigating the challenges of parenthood.

Shanghai Sand Information Technology System Co., Ltd. develops and produces financial terminal equipments and multi-media equipments for financial industry. Its products include POS terminals, cash registers and IC card readers, check readers, and net communication products. The company provides various solutions, including international card and business settlement, international card acquiring bank, document and bill information image process, personal consumption loan and foreign exchange, and IC card payment/points saving systems, as well as intermediary business self-service terminals, and multi-function self-service earmark machines. It also offers system integration and technique services for finance, telecommunication, and government areas. Shanghai Sand Information Technology System Co., Ltd. was formerly known as SAND Information Technology System Co., Ltd. The company was founded in 1994 and is based in Shanghai, China.

MicroMass is a marketing agency focused on applying evidence-based behavior change strategies to create real-world solutions that optimize patient health outcomes. The merger of SPS and MicroMass creates one of the largest independent, full-service, multi-channel healthcare marketing and medical communications agencies in the Southeast, with unique expertise in both human health behavior and healthcare professional advocacy.

Gynecare offers an endometrial ablation system for the treatment of uterine disorders. Gynecare offers devices like ThermaChoice Uterine Balloon Therapy system for the treatment of women who experience dysfunctional uterine bleeding. It also offers a VersaPoint Bipolar Electrosurgery system to treat women diagnosed with benign uterine pathologies including fibroids, polyps, adhesions, and divided septa.

Mitek Surgical Products provided bone anchors and minimally invasive surgical tools for orthopedic surgery. The company was founded by three Massachusetts Institute of Technology engineers in 1985.

Janssen, a subsidiary of Johnson & Johnson, is a pharmaceutical company focused on transforming healthcare through innovative medicines and solutions. Founded in 1953 by Dr. Paul Janssen, the company conducts extensive research and development across various therapeutic areas, including oncology, mental health, neurological disorders, gastrointestinal issues, and immunology. Janssen aims to address serious health concerns by delivering effective and affordable treatments, ensuring that patients have access to the best available care. The company is committed to improving healthcare delivery and patient outcomes through the integration of new technologies and consumer empowerment. By addressing unmet medical needs, Janssen continues to advance the science of medicine while striving to create a healthier world for all.